Experiments to optimize enzyme substitution therapy in pancreatic duct-ligated pigs.
Ligation of the pancreatic duct in pigs leads to severe maldigestion and malabsorption of crude nutrients. Supplementation with 24 capsules of Creon (Solvay Pharmaceuticals GmbH, Hannover, Germany) per meal led to an increased digestibility of crude nutrients. With regard to optimization of the treatment of EPI no essential improvements can be achieved by adding omeprazol or lecithin to the diet. In pancreatic duct-ligated pigs the isolated addition of omeprazol led to an increase of the pre-caecal digestibility of crude fat and organic matter. With additional enzyme substitution, the application of omeprazol did not result in an improved fat digestibility. Isolated addition of lecithin to the diet resulted in a reduced total digestibility of crude fat. Offering the diet twice a day and using a higher frequency of enzyme applications (four or six instead of only two applications) had no effects on the digestibilty of crude fat or organic matter. According to the observations in pancreatic duct-ligated pigs, the addition of missing enzymes to the diet led to the best treatment results in EPI. Administration of omeprazol or a higher feeding frequency as well as the application of enzymes in small proportion of the whole meal or dosages given consecutively over the day showed no advantages. Furthermore, the present study suggests that the addition of lecithin cannot be recommended in EPI, when given diets with butter as the predominant fat source as in human dietetics.
Kammlott
E
E
Institute of Animal Nutrition, University of Veterinary Medicine Hannover, Foundation, D-30173 Hannover, Germany.
Karthoff
J
J
Stemme
K
K
Gregory
P
P
Kamphues
J
J
D000821:Animal Feed; D000818:Animals; D004041:Dietary Fats / Q000378:metabolism; D019587:Dietary Supplements; D004063:Digestion / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D004798:Enzymes / Q000008:administration & dosage* / Q000378:metabolism; D010188:Exocrine Pancreatic Insufficiency / Q000188:drug therapy*; D005260:Female; D008026:Ligation; D009853:Omeprazole / Q000008:administration & dosage / Q000494:pharmacology; D010179:Pancreas / Q000201:enzymology* / Q000378:metabolism; D010183:Pancreatic Ducts / Q000601:surgery; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000494:pharmacology; D011897:Random Allocation; D013552:Swine; D013556:Swine, Miniature / Q000378:metabolism*
D004041:Dietary Fats; D004791:Enzyme Inhibitors; D004798:Enzymes; D010713:Phosphatidylcholines; D009853:Omeprazole